Preventing OHSS in PCOS women having ICSI
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a way to prevent a side effect called ovarian hyperstimulation syndrome (OHSS) in women with PCOS who are having ICSI (a type of IVF). The goal is to make fertility treatment safer for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with PCOS.
- You are coming in for an ICSI cycle (a type of IVF).
- You are 18 to 45 years old.
- You have not had ovarian hyperstimulation syndrome before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called cabergoline can lower the chance of ovarian hyperstimulation syndrome (OHSS) in women undergoing IVF who are at high risk. It compares cabergoline with a standard technique called 'coasting' (stopping fertility drugs for a few days).
This trial studies how IVF (fertility treatment) and ICSI (a lab step used with IVF) work in women with PCOS. It may help doctors understand which PCOS-related factors affect success and how to tailor care.
This trial compares two types of ovarian stimulation protocols (PPOS and antagonist) for women with PCOS undergoing IVF to see which leads to better outcomes. If you have PCOS and are planning IVF, this study may help find the best approach for you.
This study compares a milder hormone-free treatment (IVM) to standard IVF for women with PCOS. It looks at how each treatment affects your body and mind, and aims to find which option is better for first-time fertility patients.
This trial compares two fertility treatments for women with PCOS: in vitro maturation (IVM) with fresh embryo transfer versus standard IVF with frozen embryo transfer. It aims to find which approach leads to better outcomes.
This study tests a way to mature eggs outside the body for women with PCOS or high ovarian reserve. It might help avoid side effects from fertility medications.
Hear when a new Ovarian Hyper Stimulation Syndrome (OHSS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.